| Acinetobacter baumannii |
Acinetobacter baumannii |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cryptococcus neoformans |
Cryptococcus neoformans |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
MIC |
0.01 |
ug.mL-1 |
10.1021/acs.jnatprod.7b00575 |
| Escherichia coli |
Escherichia coli |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
10000.0 |
nM |
None |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
5637 |
IC50 |
1730.0 |
nM |
10.1016/j.bmc.2008.04.003 |
| Homo sapiens |
A-427 |
IC50 |
630.0 |
nM |
10.1016/j.bmc.2008.04.003 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adrenergic receptor beta |
Activity |
-5.54 |
None |
10.1016/S0960-894X(97)00046-2 |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
1253.8 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
2807.0 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
5600.7 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
8196.1 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
9196.2 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
11577.4 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
12990.0 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
15785.0 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bloom syndrome protein |
Potency |
1.6 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bromodomain adjacent to zinc finger domain protein 2B |
Potency |
794.3 |
nM |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CDGSH iron-sulfur domain-containing protein 1 |
IC50 |
nan |
None |
10.1016/j.bmcl.2016.09.009 |
| Homo sapiens |
CDGSH iron-sulfur domain-containing protein 1 |
Ki |
nan |
None |
10.1016/j.bmcl.2016.09.009 |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
223.9 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
3793.3 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
562.3 |
nM |
None |
| Homo sapiens |
DNA (cytosine-5)-methyltransferase 1 |
IC50 |
300.0 |
nM |
10.1021/acs.jmedchem.7b01926 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
E3 ubiquitin-protein ligase UHRF1 |
Activity |
0.88 |
% |
10.1016/j.ejmech.2016.02.043 |
| Homo sapiens |
E3 ubiquitin-protein ligase UHRF1 |
Inhibition |
48.0 |
% |
10.1016/j.ejmech.2016.02.043 |
| Homo sapiens |
E3 ubiquitin-protein ligase UHRF1 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2016.02.043 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Geminin |
Potency |
115.8 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
2310.9 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
2909.3 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
2985.5 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
HEK293 |
CC50 |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Homo sapiens |
HEK293 |
Potency |
4107.8 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Hemoglobin beta chain |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
HepG2 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-8.88 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-5.18 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.7b01926 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
22.4 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
8.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
T1/2 |
0.6833 |
hr |
10.1021/jm500843d |
| Homo sapiens |
HT-29 |
Activity |
nan |
None |
10.1021/np50063a010 |
| Homo sapiens |
HT-29 |
IC50 |
3800.0 |
nM |
10.1021/np50063a010 |
| Homo sapiens |
HT-29 |
IZ |
20.0 |
mm |
10.1021/np50063a010 |
| Homo sapiens |
Huntingtin |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Interleukin-8 |
Potency |
943.9 |
nM |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
1636.0 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
KB |
IC50 |
0.23 |
ug.mL-1 |
10.1021/acs.jnatprod.7b00575 |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
IC50 |
6780.0 |
nM |
10.1016/j.bmc.2008.04.003 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase B |
Activity |
nan |
None |
10.1021/jm800656v |
| Homo sapiens |
Mothers against decapentaplegic homolog 3 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Mothers against decapentaplegic homolog 3 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
500000.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
Inhibition |
50.0 |
% |
10.1021/jm301302s |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
NAD-dependent protein deacetylase sirtuin-6 |
FC |
1.3 |
None |
10.1021/acs.jmedchem.1c00601 |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
1368.5 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
1883.4 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
4109.5 |
nM |
None |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
2238.7 |
nM |
None |
| Homo sapiens |
Nuclear receptor ROR-gamma |
Potency |
3349.1 |
nM |
None |
| Homo sapiens |
Peripheral myelin protein 22 |
Potency |
30131.3 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
891.3 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
1584.9 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
116.7 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
736.2 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
14689.2 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SH-SY5Y |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
108.45 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
96.87 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Thrombopoietin |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
6683.8 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
7307.8 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
7499.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
8199.5 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
31622.8 |
nM |
None |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Activity |
10.0 |
% |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Activity |
12.8 |
% |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Activity |
17.0 |
% |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Activity |
19.1 |
% |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Activity |
25.4 |
% |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Activity |
25.8 |
% |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Activity |
60.0 |
% |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Activity |
nan |
None |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
53000.0 |
nM |
10.1016/j.bmc.2013.08.023 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
FC |
6.8 |
None |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
FC |
43.0 |
None |
10.1016/j.bmc.2016.03.052 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
FC |
67.0 |
None |
10.1016/j.bmc.2016.03.052 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Mus musculus |
B16 |
Activity |
-1.5 |
g |
10.1021/jm00216a013 |
| Mus musculus |
B16 |
ILS |
20.0 |
% |
10.1021/jm00216a013 |
| Mus musculus |
B16 |
MED |
1.5 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
Activity |
-4.1 |
g |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
Activity |
-3.8 |
g |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
Activity |
-3.0 |
g |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
Activity |
-1.5 |
g |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
Activity |
-0.5 |
g |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
Activity |
nan |
None |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
IC50 |
409.0 |
nM |
10.1021/jm00385a016 |
| Mus musculus |
L1210 |
ILS |
0.0 |
% |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
ILS |
1.0 |
% |
10.1021/jm00196a015 |
| Mus musculus |
L1210 |
ILS |
24.0 |
% |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
ILS |
26.0 |
% |
10.1021/jm00196a015 |
| Mus musculus |
L1210 |
ILS |
28.0 |
% |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
ILS |
33.0 |
% |
10.1021/jm00196a015 |
| Mus musculus |
L1210 |
ILS |
33.0 |
% |
10.1021/jm00200a012 |
| Mus musculus |
L1210 |
ILS |
63.0 |
% |
10.1021/jm00200a012 |
| Mus musculus |
L1210 |
ILS |
66.0 |
% |
10.1021/jm00196a015 |
| Mus musculus |
L1210 |
ILS |
73.0 |
% |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
ILS |
84.0 |
% |
10.1021/jm00200a012 |
| Mus musculus |
L1210 |
ILS |
86.0 |
% |
10.1021/jm00200a012 |
| Mus musculus |
L1210 |
ILS |
94.0 |
% |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
ILS |
126.0 |
% |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
ILS |
128.0 |
% |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
ILS |
130.0 |
% |
10.1021/jm00200a012 |
| Mus musculus |
L1210 |
Log CR |
1.54 |
None |
10.1021/jm00169a014 |
| Mus musculus |
L1210 |
MAD |
0.75 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MAD |
3.13 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MAD |
5.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MAD |
20.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MAD |
25.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MAD |
100.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MED |
0.75 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MED |
1.25 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MED |
1.56 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MED |
5.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
L1210 |
MED |
12.5 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
Mus musculus |
Activity |
-6.5 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
-6.1 |
g |
10.1021/jm00196a015 |
| Mus musculus |
Mus musculus |
Activity |
-5.7 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
-5.3 |
g |
10.1021/jm00196a015 |
| Mus musculus |
Mus musculus |
Activity |
-5.1 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
-4.5 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
-2.9 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
-2.3 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
-2.0 |
g |
10.1021/jm00196a015 |
| Mus musculus |
Mus musculus |
Activity |
-1.8 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
-1.6 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
-1.5 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
-1.3 |
g |
10.1021/jm00196a015 |
| Mus musculus |
Mus musculus |
Activity |
-1.0 |
g |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
Activity |
0.75 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
Mus musculus |
Activity |
1.0 |
% |
10.1021/acs.jmedchem.7b00746 |
| Mus musculus |
Mus musculus |
Activity |
3.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
Mus musculus |
Activity |
5.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
Mus musculus |
Activity |
10.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
Mus musculus |
Activity |
12.5 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
Mus musculus |
Activity |
50.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm00196a015 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm00200a012 |
| Mus musculus |
Mus musculus |
MTD |
8.0 |
mg kg-1 |
10.1021/acs.jmedchem.7b00746 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
P388 |
Activity |
-4.3 |
g |
10.1021/jm00216a013 |
| Mus musculus |
P388 |
Activity |
nan |
None |
10.1021/np50063a010 |
| Mus musculus |
P388 |
IC50 |
5000.0 |
nM |
10.1021/np50063a010 |
| Mus musculus |
P388 |
ILS |
127.0 |
% |
10.1021/jm00216a013 |
| Mus musculus |
P388 |
IZ |
12.5 |
mm |
10.1021/np50063a010 |
| Mus musculus |
P388 |
IZ |
30.0 |
mm |
10.1021/np50063a010 |
| Mus musculus |
P388 |
MAD |
3.0 |
mg kg-1 |
10.1021/jm00216a013 |
| Mus musculus |
P388 |
MED |
0.75 |
mg kg-1 |
10.1021/jm00216a013 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
5858.4 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
1122.0 |
nM |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nuclear receptor subfamily 1 group I member 2 |
Potency |
12589.3 |
nM |
None |
| Rattus norvegicus |
Nuclear receptor subfamily 1 group I member 2 |
Potency |
44668.4 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
16.1 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
6.0 |
hr |
10.1021/jm00200a012 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
3.746 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
26.88 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-5.86 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.0 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.12 |
% |
10.6019/CHEMBL4495565 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
10000.0 |
nM |
10.6019/CHEMBL4513141 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
6.0 |
nM |
None |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
756.9 |
nM |
None |
| None |
ADMET |
CL |
35.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
MRT |
0.22 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
0.36 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
TI |
7.5 |
None |
10.1021/jm00216a013 |
| None |
ADMET |
TI |
14.0 |
None |
10.1021/jm00216a013 |
| None |
ADMET |
Vdss |
0.47 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
DILI positive/negative |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Molecular identity unknown |
Potency |
9439.2 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
5.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
62.5 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
1590.0 |
nM |
10.1016/j.bmc.2008.04.003 |
| None |
NON-PROTEIN TARGET |
Potency |
3.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
4.2 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
66.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
20931.0 |
nM |
None |
| None |
No relevant target |
Drug degradation |
15.0 |
% |
10.1021/jm00196a015 |
| None |
No relevant target |
Drug degradation |
15.0 |
% |
10.1021/jm00216a013 |
| None |
No relevant target |
LogD |
-2.17 |
None |
10.1021/jm00169a014 |
| None |
No relevant target |
LogP |
-3.1 |
None |
10.1016/j.bmc.2017.08.011 |
| None |
No relevant target |
LogP |
-2.17 |
None |
10.1021/jm070524a |
| None |
No relevant target |
Solubility |
89000.0 |
ug.mL-1 |
10.1016/j.bmc.2017.08.011 |
| None |
No relevant target |
Stability |
nan |
% |
10.1021/jm00216a013 |
| None |
No relevant target |
T1/2 |
48.0 |
hr |
10.1021/jm00216a013 |
| None |
Unchecked |
Ac50 |
0.7943 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.585 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.778 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.981 |
uM |
None |
| None |
Unchecked |
Ac50 |
14.13 |
uM |
None |
| None |
Unchecked |
Ac50 |
17.78 |
uM |
None |
| None |
Unchecked |
AC50 |
794.3 |
nM |
None |
| None |
Unchecked |
AC50 |
1584.9 |
nM |
None |
| None |
Unchecked |
AC50 |
1780.0 |
nM |
None |
| None |
Unchecked |
AC50 |
3981.1 |
nM |
None |
| None |
Unchecked |
AC50 |
14125.4 |
nM |
None |
| None |
Unchecked |
AC50 |
17782.8 |
nM |
None |
| None |
Unchecked |
Activity |
50.0 |
% |
10.1016/j.bmc.2016.03.052 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01803 |
| None |
Unchecked |
EC50 |
510.0 |
nM |
10.1021/acs.jmedchem.6b01803 |
| None |
Unchecked |
EC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.6b01803 |
| None |
Unchecked |
EC50 |
10820.0 |
nM |
None |
| None |
Unchecked |
EC50 |
13990.0 |
nM |
None |
| None |
Unchecked |
EC50 |
17430.0 |
nM |
None |
| None |
Unchecked |
EC50 |
19680.0 |
nM |
None |
| None |
Unchecked |
FC |
47.0 |
None |
10.1016/j.ejmech.2021.113213 |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
500.0 |
nM |
10.1021/acs.jmedchem.6b01803 |
| None |
Unchecked |
IC50 |
1802.7 |
nM |
None |
| None |
Unchecked |
IC50 |
2550.2 |
nM |
None |
| None |
Unchecked |
IC50 |
3036.4 |
nM |
None |
| None |
Unchecked |
IC50 |
4760.0 |
nM |
None |
| None |
Unchecked |
IC50 |
6666.7 |
nM |
None |
| None |
Unchecked |
IC50 |
7400.4 |
nM |
None |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.6b01803 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
10060.0 |
nM |
None |
| None |
Unchecked |
IC50 |
10800.0 |
nM |
None |
| None |
Unchecked |
IC50 |
11223.0 |
nM |
None |
| None |
Unchecked |
IC50 |
11900.0 |
nM |
None |
| None |
Unchecked |
IC50 |
12340.6 |
nM |
None |
| None |
Unchecked |
IC50 |
12532.9 |
nM |
None |
| None |
Unchecked |
IC50 |
13240.0 |
nM |
None |
| None |
Unchecked |
IC50 |
19410.0 |
nM |
None |
| None |
Unchecked |
IC50 |
30800.0 |
nM |
None |
| None |
Unchecked |
IC50 |
33630.0 |
nM |
None |
| None |
Unchecked |
IC50 |
33960.0 |
nM |
None |
| None |
Unchecked |
IC50 |
35200.0 |
nM |
None |
| None |
Unchecked |
IC50 |
39860.0 |
nM |
None |
| None |
Unchecked |
IC50 |
42480.0 |
nM |
None |
| None |
Unchecked |
IC50 |
46170.0 |
nM |
None |
| None |
Unchecked |
IC50 |
50380.0 |
nM |
None |
| None |
Unchecked |
IC50 |
80000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1039/C3MD00214D |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Max_Activity |
26.0 |
uM |
None |
| None |
Unchecked |
Potency |
661.9 |
nM |
None |
| None |
Unchecked |
Potency |
794.3 |
nM |
None |
| None |
Unchecked |
Potency |
1412.5 |
nM |
None |
| None |
Unchecked |
Potency |
1835.6 |
nM |
None |
| None |
Unchecked |
Potency |
2511.9 |
nM |
None |
| None |
Unchecked |
Potency |
2635.1 |
nM |
None |
| None |
Unchecked |
Potency |
2818.4 |
nM |
None |
| None |
Unchecked |
Potency |
2956.6 |
nM |
None |
| None |
Unchecked |
Potency |
3162.3 |
nM |
None |
| None |
Unchecked |
Potency |
3548.1 |
nM |
None |
| None |
Unchecked |
Potency |
3662.6 |
nM |
None |
| None |
Unchecked |
Potency |
4109.5 |
nM |
None |
| None |
Unchecked |
Potency |
4176.3 |
nM |
None |
| None |
Unchecked |
Potency |
6309.6 |
nM |
None |
| None |
Unchecked |
Potency |
6513.1 |
nM |
None |
| None |
Unchecked |
Potency |
7079.5 |
nM |
None |
| None |
Unchecked |
Potency |
8196.1 |
nM |
None |
| None |
Unchecked |
Potency |
9200.0 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
14818.0 |
nM |
None |
| None |
Unchecked |
Potency |
16771.6 |
nM |
None |
| None |
Unchecked |
Potency |
26350.6 |
nM |
None |
| None |
Unchecked |
Potency |
29565.9 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Potency |
50118.7 |
nM |
None |